More on AmSurg (AMSG): Q4 comes in mixed, beating on revenue but coming up slightly short on...
More on AmSurg (AMSG): Q4 comes in mixed, beating on revenue but coming up slightly short on guidance. The company also posts mixed guidance going forward. For 2013, it expects revenue to be in the range of $1.06B to $1.09B and EPS of $2.18 to $2.23. The Street is at $1.05B in revenue and earnings of $2.24 per share.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs